Without Covid-19 jab, ‘reinfection may occur every 16 months’

Reports grow of repeat infection as experts warn prevalence among school pupils puts older people at risk

As Covid-19 infections surge in England, people are increasingly reporting catching Sars-CoV-2 for a second or even third time.

New analysis has suggested that unvaccinated individuals should expect to be reinfected with Covid-19 every 16 months, on average.

Continue reading...

Offshoot of Covid Delta variant on the rise in England

UK Health Security Agency monitoring AY.4.2 as daily cases at highest level since late July

A newly detected coronavirus variant is on the rise in England, with the virus believed to be an offshoot of Delta.

According to a briefing from the UK Health Security Agency, released on Friday, “a Delta sublineage newly designated as AY.4.2 is noted to be expanding in England”, with the body adding that the variant is being monitored and assessed.

Continue reading...

Valneva Covid vaccine could be as effective as Oxford jab, study suggests

Vaccine produced by French company uses inactivated Sars-CoV-2 virus and can be stored in fridge

A coronavirus jab based on traditional vaccine technology might be as effective as the Oxford/AstraZeneca vaccine, data suggests, offering new hope for global vaccination efforts.

Vaccines currently approved for use in the UK deliver instructions for producing the coronavirus “spike” protein to cells in order, which triggers an immune response. However, the jab produced by the French pharmaceutical company Valneva involves delivering the whole – but inactivated – Sars-CoV-2 virus.

Continue reading...

How my ivermectin research led to Twitter death threats | Dr Andrew Hill

I was sent images of coffins and hanged Nazi war criminals after finding medical fraud in clinical trials

The story of online threats and abuse is very dark. In early 2021, my research team was analysing a new drug called ivermectin. In the first clinical trials, this drug seemed to prevent new infections and improve survival. When I first wrote about this, I started getting regular threats on Twitter, demanding that ivermectin should be approved worldwide and questioning the safety of vaccines.

In March 2021, I received my first vaccine dose and posted a photo on Twitter from the clinic. Within minutes I was receiving strange messages: “Why would you do that?”, “not safe”, “why not use ivermectin instead”, “you are paid by the Gates Foundation”. One person even sent a link to a suction device to remove the vaccine fluid from my arm. Any message I sent promoting the benefits of vaccines led to threats and abuse.

Continue reading...

Local Covid vaccines fill gap as UN Covax scheme misses target

India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind

Developing countries are increasingly turning to homegrown Covid vaccinations as the UN-backed Covax programme falls behind.

While western countries roll out booster jabs to their own populations, Covax, which was set up by UN agencies, governments and donors to ensure fair access to Covid-19 vaccines for low- and middle-income countries, has said it will miss its target to distribute 2bn doses globally by the end of this year.

Continue reading...

New treatment destroys head and neck cancer tumours in trial

Exclusive: combination of drugs causes tumours to vanish in some terminally ill patients, study finds

A new cancer treatment can wipe out tumours in terminally ill head and neck cancer patients, scientists have discovered.

In a landmark trial, a cocktail of immunotherapy medications harnessed patients’ immune systems to kill their own cancer cells and prompted “a positive trend in survival”, according to researchers at the Institute of Cancer Research (ICR), London, and the Royal Marsden NHS foundation trust.

Continue reading...

Covid by numbers: 10 key lessons separating fact from fiction

To make sense of coronavirus data, the Observer asked David Spiegelhalter and Anthony Masters of the Royal Statistical Society Covid taskforce to write a column. That column has now inspired a book. Here are some of its insights

Genomic sequencing has identified more than 1,000 different seeds of Sars-CoV-2 introduced in early 2020. Instead of one central outbreak, reverberating outwards like an explosion, we now know there were many erupting simultaneously across the country. There were far more imports of Sars-CoV-2 from France, Italy and Spain than from China – viruses can take indirect flights. The peak was early March, after the school half-term, but a popular holiday time for adults. At the Champions League football match at Anfield between Liverpool and Atlético Madrid on 10 March, 49,000 local supporters mixed with 3,000 fans of the opposing team, while schools in Madrid were shut and supporters could not attend matches. To add insult to injury, Liverpool lost 3–2, and 4–2 on aggregate.

Continue reading...

Could the global Covid death toll be millions higher than thought?

A data scientist and economics student joined forces in search of the real pandemic death toll – and the results are startling

For the past 18 months, hunkered down in his Tel Aviv apartment, Ariel Karlinsky has scoured the web for data that could help him calculate the true death toll of Covid-19.

Continue reading...

WHO endorses use of world’s first malaria vaccine in Africa

World Health Organization’s director general hails ‘historic day’ in fight against parasitic disease

The World Health Organization has recommended the widespread rollout of the first malaria vaccine, in a move experts hope could save tens of thousands of children’s lives each year across Africa.

Hailing “an historic day”, the WHO’s director general, Dr Tedros Adhanom Ghebreyesus, said that after a successful pilot programme in three African countries the RTS,S vaccine should be made available more widely.

Continue reading...

‘Covid toe’ may be side-effect of immune response, says study

Chilblain-like inflammation causes redness on hands and feet and can last for months

The skin condition known as Covid toe may be a side-effect of the immune system’s response to fighting off the virus, according to a study.

The symptom results in chilblain-like inflammation and redness on the hands and feet, with the condition sometimes lasting for months at a time. It typically develops within a week to four weeks of being infected and can result in toes and fingers becoming swollen or changing colour.

Continue reading...

Woman successfully treated for depression with electrical brain implant

‘Stunning’ neuroscientific advance gives hope to those with mental illness not helped with drugs

A woman with severe depression has been successfully treated with an experimental brain implant in a “stunning” advance that offers hope to those with intractable mental illness.

The device works by detecting patterns of brain activity linked to depression and automatically interrupting them using tiny pulses of electrical stimulation delivered deep inside the brain.

Continue reading...

Coronavirus treatments: the potential ‘game-changers’ in development

After positive clinical trials for antiviral drug Molnupiravir, it joins other medicines that have shown promise

The first clinical trial results showing a positive effect for a pill that can be taken at home has been hailed as a potential gamechanger that could provide a new way to protect the most vulnerable people from the worst effects of Covid-19. Molnupiravir joins a growing list of medicines that have shown promise. Here are some of the main developments in treatments so far.

Continue reading...

Covid antiviral pill halves hospitalisations and deaths, maker says

If approved, Merck’s drug would be first simple oral medication shown to be effective against coronavirus

An antiviral pill was found to reduce hospitalisations and deaths by half in patients newly diagnosed with Covid-19, according to results announced on Friday.

If approved, the drug made by the US firm Merck and Ridgeback Biotherapeutics would be the first simple oral medication shown to be effective against Covid-19, which would mark a crucial advance in the fight against the pandemic. Other drugs, such as remdesivir, have been shown to be effective if given early, but all currently approved treatments need to be given as injections or IV infusions.

Continue reading...

Flu and Covid jabs safe to be given at same time, study finds

Clinical trial on joint flu, Pfizer and AstraZeneca vaccinations reported only mild to moderate side-effects

Flu jabs are safe to give at the same time as the Pfizer or AstraZeneca Covid vaccines, according to the first clinical trial to investigate co-administering the shots in a single appointment.

While some people experienced more side-effects with certain combinations of flu and Covid shots, the ailments were mainly mild to moderate, the study found. The most common side effects included pain at the injection site and temporary fatigue, headache or muscle pain.

Continue reading...

Hydroxychloroquine sales spiked almost 100% in Australia at start of Covid pandemic, study finds

There was also a rise in prescriptions for ivermectin being filled, despite no evidence either drug is effective against the virus

The amount of hydroxychloroquine and ivermectin dispensed from Australian pharmacies increased significantly in 2020 as the Covid pandemic took hold, according to new research.

Analysis of six publicly subsidised drugs – including hydroxychloroquine, ivermectin, corticosteroids and the common antibiotic azithromycin – found Covid-related changes in prescription patterns in Australia.

Continue reading...

Dutch scientists may have solved mystery of why some twins are identical

Discovery of DNA modifications raises hope of treatment for disorders that particularly afflict twins

The medical mystery of what causes some twins to be born identical may have been solved by scientists in the Netherlands, raising hopes for treatment of congenital disorders that disproportionately afflict them.

Identical twins form after a fertilised egg, called a zygote, splits into two embryos sharing exactly the same genes. The reason for the split is unknown.

Continue reading...

Covid can infect cells in pancreas that make insulin, research shows

Results of two studies may explain why some people develop diabetes after catching the virus

Covid-19 can infect insulin-producing cells in the pancreas and change their function, potentially explaining why some previously healthy people develop diabetes after catching the virus.

Doctors are increasingly concerned about the growing number of patients who have developed diabetes either while infected with coronavirus, or shortly after recovering from it.

Continue reading...

Covid has wiped out years of progress on life expectancy, finds study

Pandemic behind biggest fall in life expectancy in western Europe since second world war, say researchers

The Covid pandemic has caused the biggest decrease in life expectancy in western Europe since the second world war, according to a study.

Data from most of the 29 countries – spanning most of Europe, the US and Chile – that were analysed by scientists recorded reductions in life expectancy last year and at a scale that wiped out years of progress.

Continue reading...

Fraudulent ivermectin studies open up new battleground between science and misinformation

Studies suggesting ivermectin is an effective Covid treatment relied on evidence ‘that has substantially evaporated under close scrutiny’, fresh research shows

Dr Carlos Chaccour ran into difficulty when he and his colleagues began recruiting patients in Peru for their study to determine the effect of a daily dose of the anti-parasitic drug ivermectin on people infected with Covid-19.

“We would call the patient and say, ‘You have just been diagnosed with Covid and you’re eligible for this study. Are you taking ivermectin?’” he says.

Continue reading...

‘Highly effective’ ovarian cancer treatment could help thousands of women

New drug combination shrunk tumours significantly in 46% of patients with treatment-resistant form of disease

Thousands of women with ovarian cancer could benefit from a revolutionary drug combination after it was shown to shrink tumours in half of patients with an advanced form of the disease.

The pair of drugs – which work together to block the signals cancer cells need to grow – could offer a new treatment option for women with a type of ovarian cancer that rarely responds to chemotherapy or hormone therapy.

Continue reading...